Pitavastatin Sandoz 1 mg

Pitavastatin Sandoz 1 mg is a medicine authorised by Swissmedic under authorisation number 68321. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 July 2022 and the authorisation is limited until 17 July 2027. ATC code C10AA08 places the medicine in the group Lipid modifying agents.

  • Dispensing category B
  • Authorisation number 68321
  • ATC C10AA08
  • Synthetic medicines
Authorisation data
Authorisation number68321
NamePitavastatin Sandoz 1 mg
Full namePitavastatin Sandoz 1 mg, Filmtabletten
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC10AA08
First authorisation18 July 2022
Authorisation validity17 July 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Pitavastatin Sandoz 1 mg, FilmtablettenB18 July 2022
2Pitavastatin Sandoz 2 mg, FilmtablettenB18 July 2022
3Pitavastatin Sandoz 4 mg, FilmtablettenB18 July 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
730Tablette(n)C10AA0807.12.0.B
890Tablette(n)C10AA0807.12.0.B
930Tablette(n)C10AA0807.12.0.B
1090Tablette(n)C10AA0807.12.0.B
1130Tablette(n)C10AA0807.12.0.B
1290Tablette(n)C10AA0807.12.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Pitavastatin Sandoz 1 mg authorised in Switzerland?

Yes. Pitavastatin Sandoz 1 mg is authorised by Swissmedic under authorisation number 68321, data as of 01 September 2026. The authorisation is limited until 17 July 2027.

Which dispensing category does Pitavastatin Sandoz 1 mg have?

Pitavastatin Sandoz 1 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Pitavastatin Sandoz 1 mg?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com